AVEO Clinical Site

Atlanta, Georgia 30322

0 studies enrolling now · 1 studies all time

What they study most

Solid Tumors

Studies at this site

• A Phase 1 Dose Escalation Study of AV-203, an ERBB3 Inhibitory Antibody, in Subjects With Advanced Solid Tumors — Completed